Table 3. Number of CZP-ADAb positive patients at any time during 24 weeks treatment.
J-RAPID |
HIKARI |
|||||
---|---|---|---|---|---|---|
Total patients |
CZP-ADAb positive patients |
Total patients |
CZP-ADAb positive patients |
|||
Groups | N | n | % | N | n | % |
LD | 82 | 1 | 1.2 | 116 | 20 | 17.2 |
No-LD | 61 | 3 | 4.9 | 99 | 27 | 27.3 |
CZP-ADAb, antibodies to CZP; LD, loading dose.